N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide

(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, 1,8-cineole 2-exo-monooxygenase, 15 LIPOXYGENASE RETICULOCYTE ARACHIDONATE, 15 LOX 1, 15 lipoxygenase 1, 15-LOX, 15-PGDH, 15-hydroxyprostaglandin dehydrogenase [NAD+], 70 kDa lysosomal alpha-glucosidase, AI838772, ALOX15, AW493413, Acid Maltase, Acid alpha glucosidase, Aglucosidase Alfa, Albendazole monooxygenase, Albendazole sulfoxidase, Alpha-glucosidase, Arachidonate 15-lipoxygenase, Arachidonate omega-6 lipoxygenase, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR, CNR1_HUMAN, CNR2_HUMAN, CNRII, CP2C9_HUMAN, CP33, CP34, CP3A4_HUMAN, CPC9, CX 5, CYP2C, CYP2C10, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIC9, CYPIIIA3, CYPIIIA4, Cannabinoid receptor 1, Cannabinoid receptor 2, Cannabinoid receptor 2 macrophage, Capsaicin receptor, Central cannabinoid receptor, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 NF-25, Cytochrome P450 PB-1, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450, family 2, subfamily C, polypeptide 9, Cytochrome P450-PCN1, DKFZp434K0220, FLJ11090, Glucocorticoid inducible P450, Glucosidase alpha, Glucosidase alpha acid, Glucosidase alpha acid (Pompe disease glycogen storage disease type II), HLP, Hpgd, Hydroxyprostaglandin dehydrogenase 15 (NAD), LOG15, LOX15_HUMAN, LYAG_HUMAN, Lysosomal Alpha-Glucosidase, MGC104252, MGC112732, MGC126680, MGC149605, MGC88320, Microsomal monooxygenase, NAD+ dependent 15 hydroxyprostaglandin dehydrogenase, NF 25, Nifedipine oxidase, OTRPC1, OTTHUMP00000016838, OTTHUMP00000020135, OTTHUMP00000214579, OTTHUMP00000218960, OTTHUMP00000219016, OTTHUMP00000219018, Osm-9-like TRP channel 1, P450 III steroid inducible, P450 MP, P450 PB 1, P450 PCN1, P450, family III, P450C3, P450IIC9, PGDH1, PGDH_HUMAN, PHOAR1, Prostaglandin dehydrogenase 1, Quinine 3-monooxygenase, RP24-311F12.2, S-mephenytoin 4-hydroxylase, SCAN1, SDR36C1, Short chain dehydrogenase/reductase family 36C member 1, TRPV1_HUMAN, TYDP, TYDP1_HUMAN, Taurochenodeoxycholate 6-alpha-hydroxylase, Transient receptor potential cation channel subfamily V member 1, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, VR 1, Vanilloid receptor 1, Vanilloid receptor subtype 1, Xenobiotic monooxygenase, cytochrome P-450 S-mephenytoin 4-hydroxylase, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, flavoprotein-linked monooxygenase, hCB2, testis-dominant CNR2 isoform CB2

Biochemicals